
Realcan Pharmaceutical Group Co., Ltd.
SZSE:002589.SZ
3.35 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 4,983.664 | 5,060.787 | 5,340.212 | 4,578.74 | 5,733.17 | 4,830.422 | 3,068.399 | 2,018.572 | 2,049.583 | 1,177.578 | 578.518 | 648.074 | 398.099 | 307.266 | 349.681 | 255.96 | 80.083 |
Short Term Investments
| 746.725 | 0 | -1,094.092 | -770.06 | 40.79 | 198.09 | 268.629 | 2.541 | -11.549 | -6.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 4,983.664 | 5,060.787 | 5,340.212 | 4,578.74 | 5,773.96 | 5,028.512 | 3,068.399 | 2,018.572 | 2,049.583 | 1,177.578 | 578.518 | 648.074 | 398.099 | 307.266 | 349.681 | 255.96 | 80.083 |
Net Receivables
| 5,267.788 | 5,212.055 | 4,603.448 | 11,275.757 | 15,182.704 | 16,494.436 | 17,979.871 | 13,087.467 | 8,413.456 | 4,953.607 | 3,573.942 | 2,754.905 | 1,987.335 | 1,423.879 | 815.809 | 568.519 | 441.902 |
Inventory
| 734.741 | 1,119.07 | 954.515 | 2,067.938 | 2,937.58 | 3,647.604 | 4,502.029 | 3,979.601 | 1,707.217 | 1,025.406 | 710.584 | 513.356 | 385.692 | 300.846 | 191.51 | 125.475 | 107.954 |
Other Current Assets
| 94.882 | 1,137.196 | 1,921.381 | 2,749.773 | 2,647.175 | 2,522.556 | 3,053.661 | 1,990.76 | 679.79 | 295.892 | 185.814 | 74.095 | 159.708 | 66.295 | 844.604 | 25.22 | 29.408 |
Total Current Assets
| 11,081.075 | 11,539.093 | 12,819.556 | 20,672.209 | 26,494.798 | 27,757.224 | 28,659.912 | 21,078.942 | 12,850.047 | 7,452.484 | 5,048.858 | 3,990.431 | 2,888.203 | 2,098.287 | 1,385.795 | 975.173 | 659.347 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 2,238.402 | 2,277.424 | 2,297.167 | 2,526.965 | 2,667.204 | 2,650.167 | 2,070.865 | 1,800.085 | 1,094.89 | 790.14 | 450.657 | 319.463 | 156.696 | 64.64 | 50.747 | 49.636 | 41.021 |
Goodwill
| 146.668 | 146.668 | 146.685 | 620.267 | 804.507 | 1,263.915 | 3,308.41 | 3,757.057 | 1,508.664 | 463.629 | 55.535 | 30.093 | 5.299 | 3.528 | 0.599 | 0.599 | 0 |
Intangible Assets
| 440.89 | 552.391 | 624.208 | 487.926 | 230.505 | 219.678 | 173.734 | 121.8 | 74.54 | 82.825 | 76.341 | 58.08 | 59.723 | 46.771 | 39.869 | 12.89 | 13.846 |
Goodwill and Intangible Assets
| 587.558 | 699.059 | 770.893 | 1,108.193 | 1,035.012 | 1,483.593 | 3,482.143 | 3,878.857 | 1,583.205 | 546.454 | 131.876 | 88.173 | 65.022 | 50.299 | 40.468 | 13.489 | 13.846 |
Long Term Investments
| 0 | 852.029 | 1,688.157 | 1,575.877 | 736.888 | 63.548 | 0 | 94.599 | 21.448 | 13.591 | 7.136 | 3.638 | -31.244 | 0 | -0 | 0 | 0 |
Tax Assets
| 286.149 | 284.444 | 105.541 | 122.865 | 92.427 | 65.433 | 66.417 | 49.275 | 71.962 | 30.663 | 19.33 | 12.549 | 9.656 | 4.32 | 2.468 | 1.665 | 1.316 |
Other Non-Current Assets
| 1,819.137 | 1,057.257 | 649.76 | 390.866 | 263.866 | 445.309 | 556.705 | 81.258 | 35.274 | 28.363 | 20.476 | 39.98 | 32.036 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 4,931.246 | 5,170.213 | 5,511.519 | 5,724.766 | 4,795.396 | 4,708.05 | 6,176.131 | 5,904.074 | 2,806.779 | 1,409.21 | 629.474 | 463.803 | 232.166 | 119.259 | 93.683 | 64.79 | 56.183 |
Total Assets
| 16,012.32 | 16,709.306 | 18,331.075 | 26,396.974 | 31,290.194 | 32,465.274 | 34,836.043 | 26,983.016 | 15,656.826 | 8,861.694 | 5,678.332 | 4,454.233 | 3,120.369 | 2,217.545 | 1,479.478 | 1,039.963 | 715.53 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 3,382.228 | 3,722.628 | 7,714.752 | 9,791.049 | 8,274.194 | 10,666.248 | 8,720.561 | 6,483.179 | 4,457.17 | 3,419.431 | 2,413.949 | 1,760.711 | 1,425.619 | 1,061.106 | 915.644 | 605.582 | 462.242 |
Short Term Debt
| 6,091.679 | 6,556.061 | 3,839.835 | 4,165.027 | 11,220.459 | 5,192.357 | 4,922.658 | 3,655.263 | 1,922.535 | 1,583.75 | 1,272.747 | 912.713 | 640 | 563.205 | 239.108 | 180 | 110 |
Tax Payables
| 26.253 | 14.782 | 28.734 | 191.125 | 254.576 | 297.87 | 376.289 | 266.374 | 185.544 | 51.426 | 38.471 | 35.965 | 23.881 | 14.097 | 6.546 | 6.781 | 4.68 |
Deferred Revenue
| 0 | 0 | 32.432 | 2,237.796 | 2,364.119 | 4,591.34 | 0 | 133.13 | 1,743.15 | 427.814 | 163.005 | 126.657 | 37.733 | 21.434 | 11.593 | 10.55 | 30.228 |
Other Current Liabilities
| 433.104 | 467.645 | 852.684 | 122.787 | 2,360.096 | -87.722 | 7,254.212 | 5,080.203 | 1,588.924 | 402.734 | -35.141 | -31.801 | 114.481 | -237.972 | -6.408 | 13.417 | 26.719 |
Total Current Liabilities
| 9,933.264 | 10,761.118 | 12,468.437 | 16,507.784 | 20,563.363 | 20,660.093 | 21,273.719 | 15,618.149 | 8,154.173 | 5,457.341 | 3,853.031 | 2,804.245 | 2,203.981 | 1,400.437 | 1,183.445 | 805.78 | 603.64 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 331.197 | 262.11 | 69.93 | 87.694 | 231.537 | 1,326.484 | 2,075.448 | 1,668.838 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 4.737 | 0 | 1.934 | 17.5 | 18.885 | 22.851 | 21.459 | 21.718 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 48.503 | 47.482 | 38.966 | 83.558 | 181.344 | 203.099 | 159.426 | 8,457.525 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 1.619 | 1.934 | 7.282 | 261.674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 384.438 | 311.211 | 110.831 | 196.034 | 247.092 | 1,552.434 | 2,256.333 | 1,690.556 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 10,317.702 | 11,072.329 | 12,579.268 | 16,703.818 | 20,810.455 | 22,212.527 | 23,530.052 | 17,308.705 | 8,154.173 | 5,457.341 | 3,853.031 | 2,804.245 | 2,203.981 | 1,400.437 | 1,183.445 | 805.78 | 603.64 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 1,504.71 | 1,504.71 | 1,504.71 | 1,504.71 | 1,504.71 | 1,504.71 | 1,504.71 | 1,504.71 | 654.222 | 554.543 | 217.895 | 108.948 | 93.8 | 93.8 | 70 | 70 | 50 |
Retained Earnings
| 276.991 | 294.298 | 280.346 | 2,125.267 | 2,092.387 | 1,834.758 | 2,856.132 | 2,200.535 | 1,276.132 | 725.367 | 515.059 | 356.678 | 235.258 | 143.092 | 66.957 | 10.834 | 41.3 |
Accumulated Other Comprehensive Income/Loss
| 0 | 257.432 | 231.378 | 231.378 | 213.315 | 205.8 | 190.042 | 133.575 | 109.3 | 50.273 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 3,756.091 | 3,391.352 | 3,391.352 | 3,705.68 | 3,924.179 | 3,847.025 | 4,126.275 | 3,967.148 | 4,945.262 | 1,914.493 | 1,064.936 | 1,166.063 | 587.351 | 578.292 | 159.076 | 153.082 | 20.589 |
Total Shareholders Equity
| 5,537.792 | 5,447.794 | 5,407.788 | 7,567.036 | 7,469.056 | 7,186.493 | 8,451.39 | 7,805.968 | 6,875.616 | 3,194.403 | 1,797.89 | 1,631.688 | 916.409 | 815.184 | 296.034 | 233.916 | 111.889 |
Total Equity
| 5,694.618 | 5,636.977 | 5,751.807 | 9,693.157 | 10,479.739 | 10,252.747 | 11,305.991 | 9,674.311 | 7,502.653 | 3,404.353 | 1,825.301 | 1,649.988 | 916.388 | 817.108 | 296.034 | 234.183 | 111.889 |
Total Liabilities & Shareholders Equity
| 16,012.32 | 16,709.306 | 18,331.075 | 26,396.974 | 31,290.194 | 32,465.274 | 34,836.043 | 26,983.016 | 15,656.826 | 8,861.694 | 5,678.332 | 4,454.233 | 3,120.369 | 2,217.545 | 1,479.478 | 1,039.963 | 715.53 |